<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>Innovene | Mario Castellanos</title>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap.min.css" rel="stylesheet">
    
    <!-- Custom CSS -->
    <link rel="stylesheet" href="assets/css/nav.css">
    <link rel="stylesheet" href="assets/css/index.css">
    <link rel="stylesheet" href="assets/fontAwesome/css/font-awesome.min.css">
    <link rel="stylesheet" href="assets/css/carousel.css">
    <link rel="stylesheet" href="assets/css/general.css">
	<link rel="stylesheet" href="assets/css/bio.css">

    <!-- IE10 viewport hack for Surface/desktop Windows 8 bug -->
    <link href="assets/css/ie10-viewport-bug-workaround.css" rel="stylesheet">

    <!-- HTML5 shim and Respond.js for IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
      <script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
    <![endif]-->
    
  </head>
    
<!-- BODY
================================================== -->
  <body>
    
    <!-- NAV -->
    <div id='mySidenav' class='sidenav'>
      <a href='index.html'>Home</a>
      <a href='about.html'>About Us</a>
      <a href='science.html'>Our Science</a>
      <a href='pipeline.html'>Product Pipeline</a>
      <a href='investors.html'>Investor Relationships</a>
      <a href='news.html'>News & Events</a>
      <a href='investors.html'>Contact</a>
        
    </div>
    <div id='static'>
        <!-- Use any element to open the sidenav -->
        <i id='navbtn' class='fa fa-bars fa-3x' aria-hidden='true' onclick='toggle()'></i>
    </div>  
    <div class="img-responsive innoveneImage headerLabel">
		<h1> Innovene </h1>
		<p class="subHeader"> Plant-Based Therapeutics</p>
		</div>
    <!-- NAV END -->

    <h1 class="orangeHeader"> Michael J. Wassil</h1>
	
    <div class="container marketing">
	  <div class="col-md-5 about">
          <img class="featurette-image img-responsive center-block" alt="InnoveneIcon" src="assets/images/Micheal.jpg">
		  <h2>CHIEF EXECUTIVE OFFICER</h2>
        </div>
		<div class="col-md-7">
			<h3 style="margin-top:3%; color:00C853">Education </h3>
			<p class="lead">
			Mr. Wassil is a graduate of King’s College with a BS in Accounting and is a licensed CPA. 
			</p>
			
			<h3 style="margin-top:3%; color:00C853">Current Position</h3>
			<p class="lead">
			Michael Wassil is an accomplished senior management executive with over 25 years in the Life Science, Finance and Manufacturing sectors. Currently he the co-founder and principal in MacroArray Technologies, LLC - a company engaged in the development of diagnostic tests for cancer. 
			</p>
			
			<h3 style="margin-top:3%; color:00C853">Career milestones:</h3>
			<p class="lead">
			Mr. Wassil served as the Executive Vice President for 3Dimensional Pharmaceuticals and successfully managed its financial, business development activities and capital sourcing requirements. 
			</p>
			<p class="lead">
			He is a co-founder of the Eastern Technology Council “ETC”, a business organization with over 400 members. He also held Board positions with Moberg Medical, Telefactor, ETC and Big Brothers/Big Sisters.
			</p>
			</div>
			
			<div>
			<h3 style="margin-top:3%; color:00C853">Startup Experience</h3>
			<p class="lead">
			His startup exposure is manifested in the management of the financial requirements for Interspec, Inc. a company engaged in the development, manufacturing and distribution of medical ultrasound systems and software. He was driving the company’s IPO and was subsequently appointed General Manager for Interspec’s International operations. After twelve years, he guided the merger of Interspec with ATL which created the world’s largest independent ultrasound company with revenues in excess of $400 million. 
			</p>
			
			<h3 style="margin-top:3%; color:00C853">Merges and Acquisitions Best Practices</h3>
			<p class="lead">
			During his career Michael Wassil acquired a profound expertise in exit strategy execution for the companies under his management,  participating in over 50 M&A, licensing and research transactions, managing two IPO’s and negotiating business transactions with Siemens Medical, GE HealthCare, Abbott Diagnostics, Bristol Myers, Centocor, Aventis, Norsk Hydro, DuPont Pharma. 
			</p>
			
			<h3 style="margin-top:3%; color:00C853">Fundraising Know-How</h3>
			<p class="lead">
			During his career Mr. Wassil has raised in excess of $150 million in equity capital. 
			</p>
			
		</div>
		<hr class="featurette-divider">
	</div>
	
	
	
    <!-- FOOTER -->
    <footer>
	
      <p class="pull-right"><a href="#">Back to top</a></p>
      <p>© 2016 Innovene · <a href="#">Privacy</a> · <a href="#">Terms</a></p>
    </footer>

      
    <!-- Bootstrap core JavaScript
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.12.4/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="../../assets/js/vendor/jquery.min.js"><\/script>')</script>
    <script src="assets/js/bootstrap.min.js"></script>
    
    <!-- Custom -->
    <script src="assets/js/nav.js"></script>

  </body>
</html>